MoneyWorks4Me

Astal Laboratories - Quaterly Results

27 Jul 2024 Evaluate
The total revenue stands at Rs. 131.46 millions for the June 2024 quarter. The mentioned figure indicates an increase of about 867.33% as against Rs. 13.59 millions during  the year-ago period.Net Profit for the quarter ended June 2024 zoomed to 12892.31% from Rs. 0.13 millions to Rs. 16.89  millions.OP of the company witnessed a marginal growth to 24.14 millions from 0.15 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 131.46 13.59 867.33 131.46 13.59 867.33 236.48 34.28 589.85
Other Income 0.34 0.12 183.33 0.34 0.12 183.33 0.13 1.79 -92.74
PBIDT 24.14 0.15 15993.33 24.14 0.15 15993.33 11.17 0.40 2692.50
Interest 0.63 0.00 0.00 0.63 0.00 0.00 0.00 0.00 0.00
PBDT 23.51 0.15 15573.33 23.51 0.15 15573.33 11.17 0.40 2692.50
Depreciation 0.13 0.02 550.00 0.13 0.02 550.00 0.30 0.08 275.00
PBT 23.38 0.13 17884.62 23.38 0.13 17884.62 10.87 0.32 3296.88
TAX 6.49 0.00 0.00 6.49 0.00 0.00 3.02 0.16 1787.50
Deferred Tax 0.26 0.00 0.00 0.26 0.00 0.00 0.08 0.06 33.33
PAT 16.89 0.13 12892.31 16.89 0.13 12892.31 7.85 0.16 4806.25
Equity 98.46 39.90 146.77 98.46 39.90 146.77 98.46 39.90 146.77
PBIDTM(%) 18.36 1.10 1563.62 18.36 1.10 1563.62 4.72 1.17 304.78
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..